Gut Liver.
2016 May;10(3):327-329. 10.5009/gnl16109.
Patients' Preference for a Specific Anti-Tumor Necrosis Factor Agent: Korea versus Western
- Affiliations
-
- 1Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. bdye@amc.seoul.kr
- 2Inflammatory Bowel Disease Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
- KMID: 2411956
- DOI: http://doi.org/10.5009/gnl16109
Abstract
- No abstract available.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Factors Contributing to the Preference of Korean Patients with Crohn's Disease When Selecting an Anti-Tumor Necrosis Factor Agent (CHOICE Study)
- Golimumab Therapy in Ulcerative Colitis
- Role of Clusterin and Tumor Necrosis Factor Receptors on the Apoptosis of Prostate Cancer Cells
- Preoperative use of anti-tumor necrosis factor therapy in Crohn's disease: promises and pitfalls
- Anti-Tumor Necrosis Factor Monoclonal Antibody Treatment for Chronic Behcet's Disease: 3 Cases
